Mariela R. Pow-Sang, MD, Victor Benavente, MD, Julio E. Pow-Sang, MD, Carlos Morante, MD, Luis Meza, MD, Mark Baker, MD, and Julio M. Pow-Sang, MD


Cancer Control. 2002;9(4) 

In This Article


Penile cancer is an uncommon malignancy in developed countries. In the United States, 1,400 cases occur per year.[1] Higher incidence rates are seen in Africa and Asia (10% to 20%),[2] and in areas of Brazil, penile cancer accounts for 17% of all malignancies in men.[3] At the Instituto de Enfermedades Neoplasicas in Peru, 272 new cases of penile cancer were diagnosed between 1985-1997, making this disease the 23rd most common malignancy and representing 1.3% of all malignancies in men.[4] In the Western world, the usual age at presentation is in the 6th decade.[5] Penile carcinoma is typically a disease of middle-aged to older men, most commonly affecting those between 50 and 70 years of age. Younger individuals are also affected; approximately 22% of patients are less than 40 years of age.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.